These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 20546255)

  • 1. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.
    Gerich JE
    Diabet Med; 2010 Feb; 27(2):136-42. PubMed ID: 20546255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney: its impact on glucose homeostasis and hormonal regulation.
    Mitrakou A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S66-72. PubMed ID: 21864754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal glucose metabolism in normal physiological conditions and in diabetes.
    Alsahli M; Gerich JE
    Diabetes Res Clin Pract; 2017 Nov; 133():1-9. PubMed ID: 28866383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the kidneys in glucose homeostasis. Implication of sodium-glucose cotransporter 2 (SGLT2) in diabetes mellitus treatment].
    Girard J
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S35-S41. PubMed ID: 28577741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose handling by the kidney.
    Mather A; Pollock C
    Kidney Int Suppl; 2011 Mar; (120):S1-6. PubMed ID: 21358696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.
    Vallon V; Thomson SC
    Diabetologia; 2017 Feb; 60(2):215-225. PubMed ID: 27878313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution of the kidney to glucose homeostasis].
    Segura J; Ruilope LM
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():26-30. PubMed ID: 24444521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.
    Wilding JP
    Metabolism; 2014 Oct; 63(10):1228-37. PubMed ID: 25104103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the kidneys' role in blood glucose regulation.
    Triplitt CL
    Am J Manag Care; 2012 Jan; 18(1 Suppl):S11-6. PubMed ID: 22559853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaching to DM2 through sodium-glucose cotransporter-2: does it make sense?
    Segura J
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():22-25. PubMed ID: 28760221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.
    Vallon V
    Annu Rev Med; 2015; 66():255-70. PubMed ID: 25341005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitus.
    Neumiller JJ; White JR; Campbell RK
    Drugs; 2010 Mar; 70(4):377-85. PubMed ID: 20205482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.
    DeFronzo RA; Norton L; Abdul-Ghani M
    Nat Rev Nephrol; 2017 Jan; 13(1):11-26. PubMed ID: 27941935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose transporters in the kidney in health and disease.
    Vallon V
    Pflugers Arch; 2020 Sep; 472(9):1345-1370. PubMed ID: 32144488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity.
    de Souza Cordeiro LM; Bainbridge L; Devisetty N; McDougal DH; Peters DJM; Chhabra KH
    Diabetologia; 2022 Jun; 65(6):1032-1047. PubMed ID: 35290476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2.
    Ghezzi C; Loo DDF; Wright EM
    Diabetologia; 2018 Oct; 61(10):2087-2097. PubMed ID: 30132032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.
    Gallo LA; Wright EM; Vallon V
    Diab Vasc Dis Res; 2015 Mar; 12(2):78-89. PubMed ID: 25616707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose control by the kidney: an emerging target in diabetes.
    Marsenic O
    Am J Kidney Dis; 2009 May; 53(5):875-83. PubMed ID: 19324482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental type II diabetes and related models of impaired glucose metabolism differentially regulate glucose transporters at the proximal tubule brush border membrane.
    Chichger H; Cleasby ME; Srai SK; Unwin RJ; Debnam ES; Marks J
    Exp Physiol; 2016 Jun; 101(6):731-42. PubMed ID: 27164183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption.
    Li S; Wang N; Guo X; Li J; Zhang T; Ren G; Li D
    Biomed Pharmacother; 2018 Dec; 108():355-366. PubMed ID: 30227329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.